September 14, 2018 / 7:43 AM / 11 days ago

标题新闻:日本武田药品工业称以620亿美元收购制药商夏尔的交易获得中国市场监管机构的批准

以上为新闻提示,路透仅提供中文标题,不就原文报导提供中文版本,欲浏览英文报导全文,请点选

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below